171 related articles for article (PubMed ID: 36361527)
1. Genetic Polymorphisms of lncRNA
Yuan LT; Yang YC; Lee HL; Shih PC; Chen LH; Tang CH; Chang LC; Wang HL; Yang SF; Chien MH
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361527
[TBL] [Abstract][Full Text] [Related]
2. Association of LINC00673 Genetic Variants with Progression of Oral Cancer.
Su SC; Lin CW; Ju PC; Chang LC; Chuang CY; Liu YF; Hsieh MJ; Yang SF
J Pers Med; 2021 May; 11(6):. PubMed ID: 34070517
[TBL] [Abstract][Full Text] [Related]
3. Impact of Long Noncoding RNA LINC00673 Genetic Variants on Susceptibility to Diabetic Retinopathy.
Chuang CC; Yang YS; Kornelius E; Huang CN; Hsu MY; Lee CY; Yang SF
Front Genet; 2022; 13():889530. PubMed ID: 35547254
[TBL] [Abstract][Full Text] [Related]
4. Association of Functional Genetic Variants of HOTAIR with Hepatocellular Carcinoma (HCC) Susceptibility in a Chinese Population.
Li H; Tang XM; Liu Y; Li W; Chen Q; Pan Y
Cell Physiol Biochem; 2017; 44(2):447-454. PubMed ID: 29141248
[TBL] [Abstract][Full Text] [Related]
5. Rs11655237 polymorphism of LINC00673 affects the prognosis of cervical cancer by interfering with the interaction between LINC00673 and microRNA-1231.
Zhu W; Li L; Li D
J Cell Physiol; 2020 Nov; 235(11):8155-8166. PubMed ID: 31957869
[TBL] [Abstract][Full Text] [Related]
6. The expression of long non coding RNA genes is associated with expression with polymorphisms of HULC rs7763881 and MALAT1 rs619586 in hepatocellular carcinoma and HBV Egyptian patients.
Motawi TMK; El-Maraghy SA; Sabry D; Mehana NA
J Cell Biochem; 2019 Sep; 120(9):14645-14656. PubMed ID: 31009106
[TBL] [Abstract][Full Text] [Related]
7. Impact of
Sun YH; Chen LJ; Wang CH; Lee CY; Hsiao YH; Yang SF; Wang PH
J Cancer; 2023; 14(13):2529-2537. PubMed ID: 37670967
[TBL] [Abstract][Full Text] [Related]
8. LINC00673 rs11655237 C>T and susceptibility to Wilms tumor: A five-center case-control study.
Li S; Lin A; Han D; Zhou H; Cheng J; Zhang J; Fu W; Zhuo Z; He J
J Gene Med; 2019 Dec; 21(12):e3133. PubMed ID: 31657076
[TBL] [Abstract][Full Text] [Related]
9. Associations between lncRNA-related polymorphisms and hepatocellular carcinoma risk: A two-stage case-control study.
Li Y; He HC; Zhou DL; Liu Q; Zhang X; Yang XH; Ye ZL; Peng JL; Tang T; Su X; He CY
J Gastroenterol Hepatol; 2021 Jan; 36(1):233-239. PubMed ID: 32453900
[TBL] [Abstract][Full Text] [Related]
10. LncRNA H19 modulated by miR-146b-3p/miR-1539-mediated allelic regulation in transarterial chemoembolization of hepatocellular carcinoma.
Song Y; Xing H; Zhou L; Zhang N; Yang M
Arch Toxicol; 2021 Sep; 95(9):3063-3070. PubMed ID: 34251499
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphism of interleukin-16 influences susceptibility to HBV-related hepatocellular carcinoma in a Chinese population.
Li S; Deng Y; Chen ZP; Huang S; Liao XC; Lin LW; Li H; Peng T; Qin X; Zhao JM
Infect Genet Evol; 2011 Dec; 11(8):2083-8. PubMed ID: 22019522
[TBL] [Abstract][Full Text] [Related]
12. LINC00673 rs11655237 Polymorphism Is Associated With Increased Risk of Cervical Cancer in a Chinese Population.
Wang Y; Luo T
Cancer Control; 2018; 25(1):1073274818803942. PubMed ID: 30286619
[TBL] [Abstract][Full Text] [Related]
13. The role of ERCC1 and AFP gene polymorphism in hepatocellular carcinoma.
Huang YL; Wu JR; Fang M; Zhao HL; Liu ZM; Ye J; Huang LS; Zhu B
Medicine (Baltimore); 2019 Apr; 98(14):e15090. PubMed ID: 30946366
[TBL] [Abstract][Full Text] [Related]
14. The emerging role of lncRNA MEG3 and MEG3 rs7158663 in hepatocellular carcinoma.
Mohammed SR; Shaker OG; Mohamed MM; Abdelhafez Mostafa MN; Gaber SN; Ali DY; Hussein HA; Elebiary AM; Abonar AA; Eid HM; El Sayed Ali HS
Eur Rev Med Pharmacol Sci; 2022 Jan; 26(1):11-21. PubMed ID: 35049008
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA LINC00673 promotes hepatocellular carcinoma progression and metastasis through negatively regulating miR-205.
Zhang LG; Zhou XK; Zhou RJ; Lv HZ; Li WP
Am J Cancer Res; 2017; 7(12):2536-2544. PubMed ID: 29312806
[TBL] [Abstract][Full Text] [Related]
16. CD44 gene polymorphisms on hepatocellular carcinoma susceptibility and clinicopathologic features.
Chou YE; Hsieh MJ; Chiou HL; Lee HL; Yang SF; Chen TY
Biomed Res Int; 2014; 2014():231474. PubMed ID: 24971320
[TBL] [Abstract][Full Text] [Related]
17. Genetic Variants of lncRNA
Yuan LT; Chang JH; Lee HL; Yang YC; Su SC; Lin CL; Yang SF; Chien MH
J Clin Med; 2019 Sep; 8(9):. PubMed ID: 31500187
[TBL] [Abstract][Full Text] [Related]
18. Additional data support the role of
Li Y; Zhuo ZJ; Zhou H; Liu J; Liu Z; Zhang J; Cheng J; Li S; Zhou H; Zhou R; He J; Zhao Y
Aging (Albany NY); 2019 Apr; 11(8):2369-2377. PubMed ID: 31005956
[TBL] [Abstract][Full Text] [Related]
19. Association between Interleukin-18 Polymorphisms and Hepatocellular Carcinoma Occurrence and Clinical Progression.
Lau HK; Hsieh MJ; Yang SF; Wang HL; Kuo WH; Lee HL; Yeh CB
Int J Med Sci; 2016; 13(7):556-61. PubMed ID: 27429592
[TBL] [Abstract][Full Text] [Related]
20. Association of CTLA-4, TNF alpha and IL 10 polymorphisms with susceptibility to hepatocellular carcinoma.
Wang JJ; Wang ZB; Tan TC
Scand J Immunol; 2019 Dec; 90(6):e12819. PubMed ID: 31448426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
